Lymphocytic Vasculitis Associated With Mild Rejection in a Vascularized Composite Allograft Recipient: A Clinicopathological Study

Transplantation. 2020 Jul;104(7):e208-e213. doi: 10.1097/TP.0000000000003241.

Abstract

Background: Histologic criteria for diagnosing acute rejection in vascularized composite tissue allograft (VCA) have been established by the Banff 2007 Working Classification of Skin-Containing Composite Tissue Allograft, but the role of early vascular lesions in graft rejection warrants additional analysis.

Methods: We performed a retrospective study of 34 skin biopsies performed over 430 d for rejection surveillance, in Canada's first face allotransplant recipient. Three observers reviewed all biopsies to assess the nature and intensity of the inflammatory skin infiltrate. A complete histological and immunohistochemical review of the vascular components was performed with a focus on lymphocytic vasculitis, intravascular fibrin, vessel caliber, extent of injury, C4d positivity, and inflammatory cell phenotyping. We then correlated these data points to clinical and immunosuppression parameters.

Results: Acute vascular damage in biopsies that would be classified as mild acute rejection correlates with troughs in immunosuppression and subsides when immunosuppressive tacrolimus doses are increased. Grade 0 Banff rejection and Grade I without lymphocytic vasculitis were almost indistinguishable, whereas Grade I with lymphocytic vasculitis was an easy and reproducible histologic finding.

Conclusions: Our results highlight the possible relevance of vascular injury in the context of VCA, as its presence might underlie a more aggressive form of immune rejection. If these findings are validated in other VCA patients, vascular injury in mild rejection might warrant a different clinical approach.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Canada
  • Composite Tissue Allografts / blood supply
  • Composite Tissue Allografts / pathology
  • Dose-Response Relationship, Drug
  • Facial Transplantation / adverse effects*
  • Graft Rejection / diagnosis*
  • Graft Rejection / immunology
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control
  • Graft Survival / drug effects
  • Graft Survival / immunology
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / pharmacokinetics
  • Male
  • Retrospective Studies
  • Severity of Illness Index
  • Skin / blood supply
  • Skin / pathology
  • Tacrolimus / administration & dosage*
  • Tacrolimus / pharmacokinetics
  • Transplantation, Homologous / adverse effects
  • Treatment Outcome
  • Vasculitis / complications*
  • Vasculitis / diagnosis
  • Vasculitis / drug therapy
  • Vasculitis / immunology

Substances

  • Immunosuppressive Agents
  • Tacrolimus

Supplementary concepts

  • Vasculitis, Lymphocytic, Cutaneous Small Vessel